期刊文献+

复发性呼吸道乳头状瘤宿主易感基因与免疫学 被引量:1

原文传递
导出
摘要 复发性呼吸道乳头状瘤是喉部上皮组织最常见的良性肿瘤,以反复复发为特征,其发病机制与宿主易感基因及宿主免疫状态相关.找出复发性呼吸道乳头状瘤确切的发病机制,寻找对因的治疗手段迫在眉睫.本文就复发性呼吸道乳头状瘤的研究现状做一综述.
作者 任嘉铭 王军
机构地区 [
出处 《国际耳鼻咽喉头颈外科杂志》 2013年第5期-,共3页 International Journal of Otolaryngology-Head and Neck Surgery
基金 国家自然科学基金资助项目
  • 相关文献

参考文献16

  • 1Bishai D,Kashima H,Shah K. The cost of juvenile-onset recurrent respiratory papillomatosis[J].{H}Archives of Otolaryngology Head and Neck Surgery,2000,(8):935-939.
  • 2Vambutas A,Bonagura VR,Steinberg BM. Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis:correlation of TAP-1 with disease[J].{H}Clinical and Diagnostic Laboratory Immunology,2000,(1):79-85.
  • 3Carrington M,Colonna M,Spies T. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class Ⅱ region haplotypes[J].{H}IMMUNOGENETICS,1993,(4):266-273.
  • 4Powis SH,Tonks S,Mockridge I. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2[J].{H}IMMUNOGENETICS,1993,(5):373-380.
  • 5Gaudet R,Wiley DC. Structure of the ABC ATPase domain of human TAP1,the transporter associated with antigen processing[J].{H}EMBO Journal,2001,(17):4964-4972.
  • 6Vambutas A,Bonagura VR,Reed EF. Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11[J].{H}Journal of Infectious Diseases,2004,(5):871-879.
  • 7Gelder CM,Williams OM,Hart KW. HLA class Ⅱ polymorphisms and susceptibility to recurrent respiratory papillomatosis[J].{H}Journal of Virology,2003,(3):1927-1939.
  • 8Bonagura VR,Hatam LJ,Rosenthal DW. Recurrent.respiratory papillomatosis:a complex defect in immune responsiveness to human papillomavirus-6 and-11[J].{H}APMIS,2010,(6-7):455-470.
  • 9Bonagura VR,Hatam L,DeVoti J. Recurrent respiratory papillomatosis:altered CD8 (+) T-cell subsets and T (H) 1/T(H) 2 cytokine imbalance[J].{H}CLINICAL IMMUNOLOGY,1999,(3):302-311.
  • 10DeVoti JA,Steinberg BM,Rosenthal DW. Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein inrespiratory papillomatosis[J].{H}Clinical and Diagnostic Laboratory Immunology,2004,(3):538-547.

二级参考文献7

  • 1Berdowska I. Cysteine proteases as disease markers. Clin ChimActa, 2004, 342: 41-69.
  • 2Kitamura H, Kamon H, Sawa S, et al. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S acitivity in dendritic cells. Immunity, 2005, 23: 491-502.
  • 3Hsing LC, Rudensky AY. The lysosomal cysteine proteases in MHC class II antigen presentatiaon. Immunol IRev, 2005, 207: 229-241.
  • 4Johmura S, Oh-hora M, Inabe K, et al. Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK. Immunity, 2003, 18: 777-787.
  • 5Koretzky GA, Myung PS. Positive and negative regulation of T-ceil activation by adaptor proteins. Nat Rev Immunol, 2001, 1 95-107.
  • 6Davidson D, Bakinowski M, Thomas ML, et al. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol CelIBiol, 2003, 23: 2017-2028.
  • 7Mota F, Rayment N, Chong S, et al. The antigen-presenting environment in normal and human papillomavirus (HPV) related premalignant cervical epithelium. Clin Exp Immunol, 1999, 116: 33-40.

共引文献3

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部